Ad
related to: antidiabetic agents pdf printable template esl
Search results
Results from the WOW.Com Content Network
To change this template's initial visibility, the |state= parameter may be used: {{Oral hypoglycemics and insulin analogs | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Oral hypoglycemics and insulin analogs | state = expanded}} will show the template expanded, i.e. fully visible.
Current clinical practice guidelines from the AACE rate sulfonylureas (as well as glinides) below all other classes of antidiabetic drugs in terms of suggested use as first, second, or third line agents - this includes Bromocriptine, the bile acid sequestrant Colesevelam, α-glucosidase inhibitors, Thiazolidinediones (glitazones), and DPP-4 ...
Alpha-glucosidase inhibitors (AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). They are found in raw plants/herbs such as cinnamon and bacteria (containing the inhibitor acarbose ).
Generally, drugs outlined within the ATC code A10 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Anti-diabetic drugs .
Anti-diabetic drug A kind of medication that helps a person with diabetes control the level of glucose (sugar) in the blood so that the body works as it should. See also: Insulin; oral hypoglycemic agents. Antigen The substance in a foreign body which evokes production of antibodies specific to it. Antiseptic
One of the most common drugs used in T2D, metformin is the drug of choice to help patients lower their blood sugar levels. Metformin is an example of a class of medicine called biguanides. [ 34 ] The medication works by reducing the new creation of glucose from the liver and by reducing absorption of sugar from food. [ 34 ]
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.
Drugs belonging to this class are: Sitagliptin [6] (FDA approved 2006, marketed by Merck & Co. as Januvia) Vildagliptin [7] (EU approved 2007, marketed in the EU by Novartis as Galvus) Saxagliptin (FDA approved in 2009, marketed as Onglyza) Linagliptin (FDA approved in 2011, marketed as Tradjenta by Eli Lilly and Company and Boehringer ...
Ad
related to: antidiabetic agents pdf printable template esl